Staphylococcus aureus is an important community-and nosocomially acquired pathogen. This organism can be resistant to multiple antimicrobial agents, which severely limits therapeutic options in selected instances. Development of the fluoroquinolone class of antimicrobial agents advanced the possibility of an effective option for the therapy of serious infections caused by multiresistant strains of S. aureus, even by the oral route of administration. Unfortunately, shortly after introduction of these agents into clinical use the emergence of fluoroquinolone-resistant S. aureus was noted, especially among methicillin-resistant strains (6, 23, 27) . The mechanisms by which S. aureus develops resistance to fluoroquinolones has been the subject of intensive research, and these investigations have defined at least three ways by which resistance to these agents is accomplished. The first mechanism consists of a mutational alteration of DNA gyrase, an essential bacterial enzyme involved in DNA replication and repair (35) . DNA gyrase is a tetrameric protein consisting of two A and B subunits, encoded by the gyrA and gyrB genes, respectively. Fluoroquinolones interact with either the A subunit itself or a complex of DNA gyrase and DNA (through the A subunit) to inhibit enzymatic function (8) . Several point mutations in gyrA have been described that confer high-level fluoroquinolone resistance upon an organism that possesses them, with most of these mutations lying within a small region of the gene (5, 30) . The second means by which resistance to fluoroquinolones is produced is mediated by the recently described cfx-ofx locus (32) . This locus confers lower-level resistance than that seen with gyrA mutations, and the mechanism(s) by which it does so has not been investigated.
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The third mechanism of resistance consists of efflux of fluoroquinolones from the cell, which also confers relatively lower-level resistance than gyrA mutations. We and others have cloned the gene involved in such efflux (norA), and its sequence has been reported by one group (10, 34) . Fluoroquinolone efflux mediated by norA is an active process that is sensitive to protonophores, such as dinitrophenol and carbonyl cyanide m-chlorophenylhydrazone (CCCP), suggesting that the proton motive force is important in the efflux process.
Achievement of a better understanding of this and other related efflux processes may yield information important in the development of ways to circumvent this type of resistance mechanism. With this end in mind, further characterization of norA1199, the norA allele cloned in our laboratory, forms the basis of this report.
MATERIALS AND METHODS
Bacterial strains and plasmids. S. aureus SA-1199 and its ciprofloxacin-resistant derivative SA-1199B have been described previously (10) . Escherichia coli DH1QB and AG100 were used as hosts for norA1199 and its wild-type (wt) allele (see below) (4, 15) . Klebsiella pneumoniae ATCC 10031 and E. coli JM83 were used as donors of chromosomal DNAs for Southern hybridization (33; see below). S. aureus 8325-4 was used as a donor of control chromosomal DNA for pulsedfield electrophoresis experiments (22; see below). Plasmid pUC19 was obtained from Bethesda Research Laboratories (BRL), Gaithersburg, Md. NorA1199 was cloned into the polylinker region of pUC19 as described previously, and the resultant plasmid (pK21 [10] ) was transformed into both E. coli DH10B and AG100 by standard techniques (25) . Antimicrobial (10 mM Tris, 1 mM EDTA, pH 7.5). For S. epidermidis, the procedure was the same except that the concentration of lysostaphin was increased to 1.8 mg/ml and it was used in conjunction with lysozyme (0.5 mg/ml; Sigma). For E. faecalis, lysozyme (0.65 mg/ml) was substituted for lysostaphin. Gram-negative organisms were lysed directly with SDS and treated with proteinase K; this was followed by extraction and precipitation of DNA as described above.
Southern blotting. Chromosomal DNAs from organisms of interest were digested with HindIII, EcoRI, or SmaI (for pulsed-field gels, see below). Restriction fragments were separated in agarose gels, transferred to nylon membranes, and hybridized with the norA1199 probe (29) . Stringency conditions were varied for some experiments (high stringency, 42°C and 50% formamide; medium stringency, 42°C and 25% formamide; low stringency, 42°C and no formamide). Pulsed-field gels were probed only under high-stringency conditions. Positive and negative controls consisted of the probe itself and HindIII-digested bacteriophage X DNA (BRL), respectively; for pulsed-field gels, the positive control was S. aureus 8325-4 DNA, to a 262-kb fragment of which a norA probe has been shown to hybridize (32) , and the negative controls were MegaBase I and II standards (BRL).
Northern blotting. Total cellular RNAs were isolated from equal numbers of cells of SA-1199 and SA-1199B by the guanidinium thiocyanate-phenol-chloroform procedure, modified for S. aureus by use of lysostaphin (250 p,g/ml) to digest the cell wall and SDS (0.7%) to lyse protoplasts (2, 25) . RNA was separated in glyoxal-containing agarose gels and then transferred to a nylon membrane (25) . Hybridization with the norA1199 gene probe then was carried out by standard techniques (29 (21) . However, these workers did not determine the nucleotide sequence of the entire gene. To determine whether this or another mutation(s) important for fluoroquinolone resistance is present in norA1199, the nucleotide sequence of norAll99(wt) in four independent PCR-generated clones was determined as described previously and a consensus sequence was generated.
Analysis of nucleotide 1085. To generate an estimate of the incidence of occurrence of either adenine or cytosine at position 1085 of the norA locus, we designed oligonucleotide primers for use in PCR that included this site in the amplification product. The primers consisted of 5'-ACTATACA CAGCTGACAAGG-3' (norA1199 positions 677 to 696) and 5'-GAATTAGGTATGTGGATTGC-3' (complementary to positions 162 to 181 bp beyond the end of norA1199). We employed the chromosomal DNA from each of the eight clinical strains of S. aureus described previously as a PCR template. PCR parameters were identical to those outlined above. The amplification product from each DNA sample then was subjected to digestion with SfcI (New England BioLabs, Beverly, Mass.). This enzyme has a single recognition site in norA1199 that includes position 1085 (CTpurine-pyrimidine-AG). SfcI digestion of an amplification product having cytosine at this position results in restriction fragments of 408 and 323 bp, whereas the presence of adenine eliminates the site and leaves the 731-bp PCR product intact.
Cytosine is present at position 1085 of both norA199 and norA1199(wt) (see below). (34) . No pleiotropic resistance to nonquinolones developed in E. coli strains carrying pK21 (data not shown).
The MICs of norfloxacin and ethidium bromide were decreased two-and fourfold and eight and eightfold for SA-1199 and SA-1199B, respectively, in the presence of 20 ,g of reserpine per ml (data not shown).
[3HInorfloxacin uptake studies. We have shown that uptake of [3H]norfloxacin by SA-1199B is markedly reduced compared with that of SA-1199 (10). Uptake of norfloxacin by this strain is nearly normalized following addition of dinitrophenol or CCCP, agents that disrupt the proton motive force. Figure 1 shows the results of drug uptake studies with E. coli AG100 with and without pK21. The presence of pK21 markedly reduced uptake of [3H]norfloxacin, a phenomenon fully reversed by addition of CCCP. Figure 1 also shows the results of studies performed with everted membrane vesicles prepared from E. coli AG100 with and without pK21. Addition of an energy source (lactate) resulted in a slight increase in vesicle-associated [3H]norfloxacin for the plasmid-free strain and a marked increase in the vesicle-associated drug in the strain carrying pK21. Addition of CCCP to the system resulted in swift loss of the drug from vesicles. Nucleotide sequence of norA1199. The nucleotide sequence of the S. aureus chromosomal DNA contained in pK21 is shown in Fig. 2 . This 2,627-bp clone contained two putative open reading frames (ORFs), one on each of the complementary strands. The largest of these (1,167 bp) reads from left to right in Fig. 2 and is norA1199. This gene encodes a 388-amino-acid polypeptide very similar to that encoded by norA (34; see Fig. 3) . At the DNA level, norA1199 and norA are 91% homologous, and their deduced protein products are 95% homologous. Clearly, norA1199 is an allele of norA. A search of available data banks revealed that the norA1199 protein has significant homology with several tetracycline (Tet) efflux proteins, including those encoded by E. coli plasmid pBR322 (24%), E. coli transposon TnlO (23%), and Bacillus stearothermophilus plasmid pTHT15 (21%). Other proteins to which some homology exists include the S. aureus qacA protein (19%), a membrane-based polypeptide involved in the efflux of intercalating dyes and quaternary ammonium-type antiseptic compounds (24), the rat brain glucose transporter (17%), and the xylose-H+ transporter (19%), the arabinose-H+ symport (19%), and the lactose permease (18%) of E. coli. The highest degree of homology *C 2.5 - was to the product of the B. subtilis bmr gene, the Bmr protein (45%), an integral membrane polypeptide capable of mediating the active efflux of several structurally unrelated compounds, including fluoroquinolones (18, 19) . In Fig. 3 , the homology between the deduced protein products of norA1199 and norA, the B. subtilis Bmr protein, and a representative Tet protein, that from pBR322, is apparent.
A second putative ORF (ORF A) is present on the strand complementary to that which encodes the norA1199 protein. ORF A reads from right to left in Fig. 2 , and as for norA1199, it is preceded by appropriate promoter-like sequences, the -35 region of which overlaps that of norA1199. The entire coding region is not contained within the cloned DNA, but translation of the partial sequence revealed an abbreviated polypeptide (88 residues) with some sequence similarity to ORF 188 (19%; putative qacA regulatory protein [24] ) and the TetR repressor from TnlO (21%; 1).
A Kyte-Doolittle plot of the norA1199 protein, with that of norA superimposed for comparison, is shown in Fig. 4 (11) . There are 12 hydrophobic domains, 6 each of which are placed on either side of a central hydrophilic region. The plots for the Tet protein of pBR322 and the B. subtilis Bmr protein are very similar in appearance (data not shown). As shown in Fig. 4 ANTIMICROB. AGENTS CHEMOTHER. (Fig. 5) . The hybridization signal for SA-1199B was significantly stronger than that for SA-1199.
Pulsed-field electrophoresis. The SmaI restriction patterns of SA-1199 and SA-1199B were identical but differed somewhat from that of S. aureus 8325-4 (Fig. 6) . The probe hybridized with a 262-kb fragment of S. aureus 8325-4 DNA (Pattee D fragment [22] ) and an identical-size fragment in strains SA-1199 and SA-1199B. The intensities of the hybrid-*t ization signals for both strains were identical (densitometric scanning; data not shown).
Nucleotide sequence of norA1199(wt). The consensus nucleotide sequence of norAll99(wt) revealed no differences from norA1199 over the entire coding region (data not shown). All four PCR-generated clones possessed a cytosine at position 1085 and an alanine at position 362 of the deduced protein product. The single difference that was identified was the presence of thymine at position -89 of norAll99(wt) instead of the adenine found at this position in norA1199.
One of the PCR-generated clones contained no Taq DNApolymerase-induced errors throughout the coding region and was found to confer norfloxacin resistance upon an E. coli host organism. The plasmid containing this clone was named pK38, and compared with a plasmid-free strain, its presence resulted in an 8-fold rise in the norfloxacin MIC for E. coli (16, 31) . Active efflux of selected antibiotics has been described for several genera of bacteria and is one mechanism by which such organisms resist the inhibitory or lethal effect(s) of these drugs. The most-studied antimicrobial agent efflux system is that for Tet. A family of highly related tet genes have been described, and their protein products are integral membrane polypeptides that are Tet-H+ antiporters the functions of which are dependent upon the proton motive force (13) . Tetr of this type tends to be plasmid or transposon based and is widespread among both gram-positive and -negative bacteria. The norA1199-encoded protein has many similarities to Tet proteins. It has significant homology with many of them, and its hydropathic profile is similar to those of Tet proteins (suggesting that it also is an integral membrane protein). Additionally, on the basis of [3H]norfloxacin uptake studies using whole cells and everted membrane vesicles (in which drug uptake is equivalent to drug efflux in whole cells), it mediates the efflux of a drug and its activity is dependent upon the proton motive force. However, the norA1199 protein differs from Tet proteins in that it originates from a chromosomal gene that occurs naturally in the S. aureus genome and it does not confer Tetr. Southern hybridization data also indicate that related sequences are present in the S. epidermidis genome.
No similar gene appears to be present in the E. faecalis genome or in gram-negative organisms, such as E. coli and K pneumoniae. The polymorphism in the restriction fragment sizes of the S. aureus and S. epidermidis DNAs that hybridized with the norA1199 probe likely is the result of point mutations in both genomes leading to acquisition or loss of restriction endonuclease recognition sites.
An even higher degree of homology than that seen with Tet proteins exists between the norA1199-encoded protein and the B. subtilis Bmr protein, which is an integral membrane polypeptide 389 amino acids long. This protein also does not confer Tetr, but it does mediate the efflux of structurally unrelated compounds, such as chloramphenicol, ethidium bromide, and tetraphenylphosphonium bromide, and also is capable of efflux of fluoroquinolones (18, 19) . The function of Bmr is interfered with by reserpine and verapamil, compounds that also inhibit the function of the mammalian multidrug efflux transporter P-glycoprotein. P-glycoprotein confers resistance to structurally unrelated antineoplastic agents in selected tumor cells (9) . ATP hydrolysis is a requirement for the function of P-glycoprotein, differentiating it from both the norA1199 protein and Bmr. In addition, Bmr and the norAI199-encoded protein have minimal homology with any P-glycoprotein species. Neyfakh et al. have cloned norAII99 into a B. subtilis vector and have observed expression of the gene in a B. subtilis host (20) . In this system, the norA1199-encoded protein functions as a multidrug efflux transporter and its activity is inhibited by reserpine. With respect to norfloxacin and ethidium bromide, we have found the same to be true in both SA-1199 and SA-1199B, as reserpine reduces the MICs of both compounds for both strains. That the wild-type strain is affected at all suggests that norA1199(wt) functions endogenously at a low level. We previously have published [3H]norfloxacin uptake data for SA-1199 and SA-1199B that also support this conclusion (10) .
The reason why the norAll99-encoded protein (and the norA-encoded protein) transports hydrophilic fluoroquinolones much more effectively than hydrophobic ones is not clear. Possibly these proteins form, or are part of, channels through the cytoplasmic membrane through which hydrophilic compounds preferentially pass, possibly unidirectionally (outward). Alternatively, the norA1199-encoded protein may function as a carrier protein with a greater affinity for hydrophilic compounds. Hydrophobic compounds may not be able to utilize either of the above-described systems efficiently. Since norAII99 (and its allele [s] ) is a naturally occurring S. aureus gene, its protein product must have a function other than fluoroquinolone transport, as these compounds are completely synthetic substances not likely to be encountered in nature. Discovery of its natural function may help to explain the preferential transport of hydrophilic fluoroquinolones.
The existence of ORF A upstream of norAII99 suggests an intriguing possibility. The regulatory proteins for both the S. aureus qacA gene and the tet gene of TnlO are encoded by genes upstream of and on the strand complementary to that of the genes they regulate (1, 24) . The distance between the resistance determinant and the regulatory gene is small, and portions of the promoter sequences overlap in both the qacA and TnlO tet situations, similar to the circumstance that exists between norAII99 and ORF A. An area of dyad symmetry, consisting of an 8-bp inverted repeat which may represent a regulatory protein-binding site, is present upstream of norAII99 (Fig. 2) . It is possible that ORF A encodes a regulatory protein that recognizes this putative regulatory region and controls transcription of norA1199. Determination of the complete nucleotide sequence of ORF A would be the first step in a more complete evaluation of the possible functions of the encoded protein, and we do possess earlier clones containing additional nucleotides upstream of norA1199 that should contain the entire coding region.
The sequence data for norA1199(wt) differ from those reported by Ohshita et al. (21) . There is no mutational alteration of residue 362 in the norAll99-encoded protein. In fact, no nucleotide differences between norAll99 and its wt allele were identified throughout the coding region. How-ever, our site-directed mutagenesis data do verify the findings of Ohshita et al. that substitution of aspartic acid for alanine at residue 362 of the norA1199-encoded protein reduces its ability to confer norfloxacin resistance upon an E. coli host. The activity of the protein is not completely eliminated; its presence confers a stable twofold increase in the norfloxacin MIC for E. coli DH10B compared with a plasmid-free strain (0.08 versus 0.04 ,ug/ml, respectively).
This twofold rise also was found by Ohshita et al. by using a different E. coli host strain. Despite this apparent agreement, additional data we have generated lead us to a different conclusion regarding the putative adenine-to-cytosine mutation at position 1085 that Ohshita et al. have concluded is responsible for converting a wild-type norA allele into one that confers hydrophilic fluoroquinolone resistance. SfcI analysis of PCR amplification products generated from all of the S. aureus strains that we have examined verified the presence of cytosine at position 1085, and sequencing data verified the presence of the same nucleotide at this position in both norA1199 and norA1199 [wt] . These data indicate that cytosine likely is the naturally occurring nucleotide at this position. Ohshita et al. studied fluoroquinolone-susceptible and -resistant strains of S. aureus that were not isogenic; it is possible that their wt strain actually possessed a cytosineto-adenine transition at position 1085. Why this substitution has such a negative effect will be the subject of future studies.
Our data indicate that rather than a mutational alteration in the norA1199 gene, increased transcription of norA1199 is the likely mechanism of fluoroquinolone resistance in SA-1199B. Northern hybridization data showed a much stronger mRNA signal for SA-1199B than for SA-1199 (Fig. 5) . On the basis of Southern hybridization studies of pulsed-field gels, gene amplification as a mechanism of resistance did not occur (Fig. 6 ). Gene amplification is the mechanism behind the multidrug resistance phenotype for cells carrying the B.
subtilis bmr gene and is one mechanism by which mammalian tumor cells expressing P-glycoprotein resist the effects of selected antineoplastic agents (9, 19) . Increased transcription of norA1199 may be the result of an unidentified alteration in the regulatory mechanism(s) for the gene, possibly involving ORF A. Additionally, the thymine [norAll99(wt)]-to-adenine (norA1199) transversion at position -89, which lies just downstream of the -10 region of the promoter, may have some effect on transcription of the gene. This transversion also may have something to do with the fact that norA1199(wt) confers a slightly lower degree of norfloxacin resistance upon E. coli DH10B than does norA1199 (MICs, 0.31 and 1.25 ,g/ml, respectively). Sitedirected mutagenesis experiments will allow determination of the importance of this nucleotide in the expression of the resistance phenotype.
Expression of norfloxacin resistance in E. coli DH10B carrying norA1199(wt) on a multicopy plasmid (pK38) supports the conclusion that an increased quantity of the protein product is responsible for the resistance observed. However, in plasmid-containing E. coli strains this increased quantity is the result of increased gene dosage rather than increased transcription of a single copy of the gene. Additional evidence favoring increased transcription of norA1199 as the basis for fluoroquinolone resistance in SA-1199B would be obtained by placing norA1199(wt) under the control of an inducible promoter. Induction to various levels of transcription should correlate with the level of fluoroquinolone resistance in the E. coli host strain.
